Next Week: The State of the FDA, One Year In
|
Hi! The past year has reshaped how biopharma communicators engage with the FDA in ways that are still settling into place. Familiar FDA contacts are gone, workflows feel less predictable, and the steady drumbeat of updates from federal agencies can be hard to translate into clear next steps. Even the most seasoned teams are asking the same question: How do we work effectively with the agency now? While this may sound like a U.S.-centric topic, the implications are far broader. As a global network, we see firsthand how shifts in FDA leadership, policy, and posture ripple across markets, influence global regulatory norms, and shape the geopolitical environment for our industry worldwide. For this reason, our January T2B Comm Convo will be focused on addressing what’s actually changed with the FDA, and how communicators can navigate this new environment. January T2B Comm Convo: State of the FDA, One Year In📅 Tuesday, January 27th
This session will be off the record and will NOT be recorded. The only way to see it is live on Tuesday. Join us to explore:
Featured speakers include Michael Pratt, Chief Communications Officer, National Pharmaceutical Council, Morrie Ruffin, Managing Partner and Founder, Adjuvant Partners, and more! Whether you come from a government or public affairs background or are a corporate communications expert, this conversation promises to be relevant for all of us. Hope you’ll join us, Lynnea |
T2B Monthly
Hi! Misinformation has become part of the backdrop of comms work, often surfacing in ways that don’t have a clear owner, a clean definition, or an obvious playbook. This is especially true in our industry, where information moves quickly, context gets lost, and trust is uneven across audiences. Biopharma communicators are navigating fragmented information ecosystems, rising skepticism, and new dynamics driven by social media and AI-accelerated content. The challenge isn’t always about...
Hi! Tomorrow we’ll be hosting the first T2B Comm Convo of 2026, focused on the state of the FDA one year into the current administration. While this topic may seem very specific, our speaker prep call reiterated that what’s happening at the FDA and adjacent government agencies right now, of course, goes well beyond this being a regulatory or government affairs issue... because it's also shaping how our decisions as communicators get framed, how risk is managed, and how we advise leadership....
Hi! A quick note to flag two timely Culture Connect updates: Happening today — Bridging Generational Gaps: Communicating Across Four Generations in Biotech With four(!) generations working side by side, expectations around feedback, leadership, and collaboration don’t always line up. Today’s virtual, interactive session @ noon ET will dig into how those differences show up at work, and what communicators can do to help teams connect more effectively. Author Erin-Kate Whitcomb (Good Work: How...